Polymer Synthesis and Characterization
PMPC-b-PDPA was prepared by loading a round bottom flask (equipped with a magnetic stir bar) with 2-methacryloyloxyethyl phosphorylcholine (MPC, 25 eq.), 2-(4-morpholino)ethyl 2bromoisobutyrate (ME-Br) initiator (1 eq.) and ethanol (final [MPC] = 2.8M), and this solution was deoxygenated by purging N2 for at least 1 h under stirring at room temperature. Then, 2,2'-bipyridine (bpy) ligand (2 eq.) and Cu(I)Br (1 eq.) were added as solids whilst maintaining the flask under a mild positive N2 pressure. The reaction was carried out under a N2 atmosphere at 30 °C. After 90 min (MPC conversion > 99% from 1 H-NMR), an ethanolic solution of 2-(diisopropylamino) ethyl methacrylate (DPA, 85 eq., [DPA] = 3.8 M), previously deoxygenated by purging N2, was injected into the flask. After 48 h, the reaction solution was opened to air, diluted with ethanol and left stirring for 1 h. The solution was then passed through a silica column to remove the copper catalyst. After this step, the filtrate was concentrated by rotary evaporation and dialysed using a 3.5 kDa MWCO dialysis membrane (Spectrum Labs, Netherland) against chloroform/methanol 2:1 (v/v) (2-3 × 500 mL), methanol (2 -3 × 500 mL), and double-distilled water (4 -6 × 2 L). After dialysis the copolymer was isolated by freeze-drying. Cy5-labelled PMPC-b-PDPA was prepared as above but using bis[2 -(2bromoisobutyryloxy)ethyl] disulfide as initiator [1] . After purification and isolation, an aliquote of the obtained polymer was reacted with Cyanine5 maleimide (1.1 eq.) and PPh3 (2 eq.) in degassed chloroform/methanol [2:1 (v/v)]. The final polymer concentration was 1.6 mM, and the reaction was kept stirring under N2 and in the dark at room temperature for 48 h. After this time, the reaction solution was opened to the air, filtered onto a silica column and dialysed using a 3.5 kDa MWCO dialysis membrane (Spectrum Labs, Netherland) against chloroform/methanol 2:1 (v/v) (2 -3 × 500 mL), methanol (4 -6 × 500 mL), and double-distilled water (4 -6 × 2 L). After dialysis the copolymer was isolated by freeze-drying. Regarding the characterization study, HPLC analyses resulted in the drug encapsulation and loading efficiencies within PMPC-PDPA polymersomes. The drug encapsulation efficiency (EE) was calculated as the ratio between the final and initial mass of loaded prednisolone disodium 21phosphate (PDP). The drug loading efficiency (LE) was determined according to a previously reported method [2] represented as the number of PDP molecules loaded within the total lumen volume of PMPC-PDPA polymersomes (which is related with the size of the vesicle and the actual amount of loaded drug). 
Drug Release study
To examine the kinetics and mechanism of PDP release from the PMPC-PDPA polymersomes, the data obtained from the in vitro drug release studies of each pH profile was analyzed using various models, including the zero and first order, Higuchi, Hixson-Crowell and Korsmeyer-Peppas models [4, 5] . Table S1 . Mathematical models for drug-release kinetics.
Release Model

Equation 1 Information
Zero-Order Q = Q0 + K0t refers to the process of constant drug release from a drug delivery device
First-Order
Log C = Log C0 -k1t / 2.303
represents a system where the release rate of the drug depends on the concentration of the drug in the system
Hixson-Crowell
describes the release from systems where there is a change in surface area and diameter of particles Higuchi Qt = kH (t) 0.5 assumes that the drug's release is caused primarily by a diffusion mechanism Korsmeyer-Peppas F=Mt/M N = Kt n provides insight into the type of drug release mechanism taking place from swellable devices 1 Q is the amount of drug released or dissolved; Q0 is initial amount of drug in solution; C0 is the initial concentration of drug; t is the time in hours; F is the fraction of drug release at time t; Mt/M is the fraction of drug released at time t; K are the rate constants for each models. For the RT-qPCR experiments, the ribosomal protein L13A (RPL13A) was used as reference gene, because it was stably expressed in THP-1, both in stimulated and unstimulated cells (data not shown). Table S3 . Forward (Fw) and reverse (Rv) gene sequences of designed primers (PRIMER-BLAS; Sigma-Aldrich) used for gene expression studies.
Gene
Primers Classification RT-qPCR data was analysed using the comparative cycle threshold (Ct) method, also known as the ΔΔCt method. The Ct value of each target gene (TNFα, IL1β, IL6 and IL8) was normalized to the reference gene (RPL13A), obtaining the ΔCt value (Equation 1) of treatment and control (i.e., nontreated). Then, the change in Ct is compared against the control to obtain the ΔΔCt value (Equation 2) using the following equations: ΔCt = Ct (target gene) -Ct (RPL13A) (1) ΔΔCt = ΔCt (treated) -ΔCt (non-treated) (2) Then, the -ΔΔCt values corresponds to the folds in gene expression change of the treated compared to the non-treated group.
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